RESOLIAN BIOANALYTICS

View On IPO.GOV.AU

Protected: Registered/protected

Last updated on 26 Sept 2023

Owner Info

Alliance Pharma Inc.

Great Valley Corporate Center,

17 Lee Boulevard, UNITED STATES OF AMERICA

Serial Number

2355826 filed on 31 Mar 2023

Correspondent

Christopher D. Olszyk, Jr. Fox Rothschild LLP

997 Lenox Drive, Bldg. 3,

Lawrenceville NJ 08648-2311,

UNITED STATES OF AMERICA

RESOLIAN BIOANALYTICS

Classification Information

2355826

31 Mar 2023

31 Mar 2033

WORD

15 Feb 2023

Status Date	Action Taken
26^th Sept 2023	International Registration in Australia Protected correspondence sent
25^th Sept 2023	IP Right Registration Published
25^th Sept 2023	Status change to Registered/Protected
16^th Jul 2023	Application Accepted correspondence sent
16^th Jul 2023	IP Right has been Examined
16^th Jul 2023	IP Right Acceptance Published
17^th May 2023	Status change to Accepted
15^th May 2023	Awaiting examination
15^th May 2023	Examination expedited
11^th May 2023	IP Right Filed Published